Related Experiment Videos

Persistent HIV-2 infection of rhesus macaque, baboon, and mangabeys

I Nicol1, G Flamminio-Zola, P Dubouch

  • 1Laboratoire de physiologie cellulaire, Université Pierre-et-Marie-Curie, Paris, France.

Intervirology
|January 1, 1989
PubMed

Insights

This study shows that infecting monkeys with human immunodeficiency type 2 (HIV-2) creates a viable animal model. This model can be used to test new HIV-2 vaccines and immunotherapies.

Area of Science:

  • Primate Virology
  • Immunology
  • Infectious Diseases

Background:

  • Human immunodeficiency type 2 (HIV-2) infection is a significant global health concern.
  • Developing effective vaccines and immunotherapies requires suitable animal models for research.

Purpose of the Study:

  • To evaluate the potential of nonhuman primates as an animal model for studying HIV-2 infection.
  • To assess the infectivity and persistence of HIV-2 in different primate species.

Main Methods:

  • Six monkeys from three species (mangabey, macaque, baboon) were inoculated with HIV-2.
  • Viral expression was confirmed via reverse transcriptase activity and electron microscopy.
  • Serological analysis included Western blot, ELISA, and neutralization assays; proviral DNA was detected by genomic analysis.

Main Results:

  • All six inoculated primates seroconverted within one month and remained persistently infected for 6-11 months.
  • Proviral DNA was consistently detected in all tested samples.
  • No clinical signs of immunodeficiency disease were observed in the infected animals during the study period.

Conclusions:

  • Nonhuman primates infected with HIV-2 serve as an acceptable animal model for investigating vaccination strategies.
  • This model is suitable for evaluating specific immunotherapeutic procedures against HIV-2.

Related Concept Videos